Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor Canal Block for ACL Surgery
NCT05532618Completed
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in anterior cruciate ligament injury comparing Levobupivacaine with Placebo (2 arms). Primary endpoint: Postoperative pain level at 48 hours. Started Aug 2022; status: completed.
02
Drugs
levobupivacaine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT05532618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05532618.